Drug Database
Back to search

United Kingdom· GB-APID-44005411000001106

Caffeine 250mg/2ml / Sodium benzoate 250mg/2ml solution for injection ampoules

A caffeine and sodium benzoate product containing caffeine + sodium benzoate, registered in United Kingdom by Special Order. The same ATC class is registered in 2 of our 19 countries.

ATC V04CG30

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCaffeine 250mg/2ml / Sodium benzoate …ATCV04CG30REGISTER NO.GB-APID-4400541100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about caffeine + sodium benzoateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Caffeine and sodium benzoate is registered in 2 of 19 countries.

Countries holding a registration under ATC V04CG30 (caffeine and sodium benzoate), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
Search caffeine and sodium benzoate products by name

Caffeine and sodium benzoate · ATC V04CG30

2 / 19 countries

  • Japan
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Caffeine + Sodium benzoate
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
V04CG30
ATC class
Caffeine and sodium benzoate
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5020850349512

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V04CG30

Caffeine and sodium benzoate, as other registers publish it.

All caffeine and sodium benzoate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3a83a1d5-70e7-452e-8a54-825584ff4e60
GET /v1/drugs/3a83a1d5-70e7-452e-8a54-825584ff4e60?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "44005411000001106",
  "desc": "Caffeine 250mg/2ml / Sodium benzoate 250mg/2ml solution for injection ampoules (Special Order)",
  "form": "Solution for injection",
  "vpid": "44007711000001106",
  "source": "dmd",
  "vtm_id": "774974002",
  "strength": "125 mg",
  "substance": "Caffeine + Sodium benzoate",
  "ingredient": "Caffeine anhydrous",
  "supplier_code": "8286711000001104"
}
API referenceMCP serverPlans

See everything about caffeine and sodium benzoate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console